Data Bytes: strategics piling into biotech venture rounds

The number of venture rounds involving corporate VC arms has continued to tick upward. The first half of 2020 has already seen 60 biotech rounds that include participation from at least one corporate VC vs. 83 such rounds in all of 2019.

Corporate VCs have been a growing part of the investment landscape since 2008 when they stepped in to fill a void created by the financial crisis (see “Pharma Ventures Earlier”). ...